BioNTech SE Sponsored ADR
BNTX Healthcare Biotechnology
BioNTech SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 9.07% from fiscal 2024.
- Revenue
- −16.4%
- EPS
- +708.4%
- Free cash flow
- −123.8%
- Total debt
- +44.4%
Quarter to September 2026, against a year earlier
Follow BNTX
Alert me
BioNTech SE Sponsored ADR (BNTX) Operating margin
BioNTech SE Sponsored ADR's operating margin over the twelve months to 30 September 2026 was −79.0%, down 30.0 percentage points from fiscal 2025 (−49.0%). Over the past ten years it has ranged from −205.8% (fiscal 2017) to 80.5% (fiscal 2021); the current reading is higher than 33% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −49.0% | (1.18) |
| FY2024 | −47.8% | (65.85) |
| FY2023 | 18.1% | (54.95) |
| FY2022 | 73.0% | (7.51) |
| FY2021 | 80.5% | 97.63 |
| FY2020 | −17.1% | 150.07 |
| FY2019 | −167.2% | (124.95) |
| FY2018 | −42.2% | 163.59 |
| FY2017 | −205.8% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 9.70% | 907.52 |
| Jun 2026 | −897.8% | (324.15) |
| Mar 2026 | −573.7% | (532.65) |
| Dec 2025 | −41.0% | (37.93) |
| 24 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| GMAB Genmab A/S Sponsored ADR compare | 26.0% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| INCY Incyte Corporation compare | 10.4% |
| INSM Insmed, Inc. compare | −37.1% |
| BBIO BridgeBio Pharma, Inc. compare | −38.5% |
| BNTX BioNTech SE Sponsored ADR | −79.0% |
| ROIV Roivant Sciences Ltd. compare | −7,914.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BNTX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement